Clinical efficacy of a Chinese herbal gel plaster combined with manipulation for lumbar disc herniation: a prospective, randomized, double-blind, placebo-controlled trial

中药凝胶膏药联合手法治疗腰椎间盘突出症的临床疗效:一项前瞻性、随机、双盲、安慰剂对照试验

阅读:1

Abstract

BACKGROUND: Haitongpi Formula, derived from the Traditional Chinese Medicine (TCM) classic Yizong Jinjian, has shown efficacy for low back pain, fractures, and osteoarthritis. Haitongpi Formula Gel Paste (HTPGP) is a modern dosage form of this formula, but clinical evidence on its effectiveness and safety remains limited. This study was designed to evaluate the clinical efficacy and safety of HTPGP combined with manipulation in relieving chronic pain caused by lumbar disc herniation (LDH). METHODS: Adults aged 40-60 years with LDH were randomly assigned to receive Qing dynasty three-movement manipulation plus HTPGP or placebo plaster (PLAGP) for 2 weeks, with 4 weeks of follow-up. The primary outcome was pain intensity measured by the visual analog scale (VAS); secondary outcomes included the Oswestry Disability Index (ODI) and surface electromyography (sEMG). Analyses were performed using generalized estimating equations, repeated-measures ANOVA, and Mann-Whitney U tests. RESULTS: Between October 2024 and June 2025, 100 eligible participants were randomized (HTPGP vs. PLAGP, 1:1). The HTPGP group demonstrated significantly greater VAS improvement from day 7 onwards (Z = 2.644-4.332). ODI scores were consistently lower in the HTPGP group (main effect F = 33.43; time effect F = 227.21; interaction F = 17.19). No significant between-group differences were observed in sEMG outcomes, and no serious adverse events occurred. CONCLUSION: In patients with LDH, HTPGP combined with manipulation provided greater pain reduction and better functional improvement than those observed in the placebo group, with a favorable safety profile. Larger randomized trials are required to confirm these findings. TRIAL REGISTRATION: The trial was registered with the International Traditional Medicine Clinical Trial Registry (http://itmctr.ccebtcm.org.cn/; No. ITMCTR2024000077).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。